SARS ABSTRACTS Proceedings of the International Symposium on the Pathogenesis of SARS
Xiaobo Zhong,Chun Wu,Rui Chen,Qingfa Wu,Jun Wang,Jian,Wang,Patricia Bray-Ward,Xing Wang Deng,David Ward,Yiming A. Chen,Yiping Shih,Yuting Lin,Chihong Chao,Yuching,Lan,Chiayen Chen,Chengming Lee,Shaohung Wang,Techeng,Lien,Houryoung Chen,KWang Jen Hsaio,Yan Hwa Wu-Lee,Guangfa Wang,Nan Li,Ligong Nie,Haichao Li,Chengli Que,Xiaoyuan Xu,Haiying Lu,Guiqiang Wang,Zhidong Gao
2004-01-01
Abstract:65. Towards the development of a test for SARS virus detection at early infection stages Xiaobo Zhong, Chun Wu , Rui Chen, Qingfa Wu, Jun Wang, Jian Wang, Patricia Bray-Ward, Xing Wang Deng and David Ward. 1 PekingYale Joint Center for Plant Molecular Genetics and Agrobiotechnology, College of Life Science, Peking University, Beijing 100871, China; 2 Dept. of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA; 3 Dept. of Molecular, Cellular, Developmental Biology, Yale University, New Haven, CT 06511, USA; 4 Beijing Genomic Institute, Beijing Airport Industrial Zone B6, Beijing 101300, China. There is a tremendous need for a test that can detect SARS at early stages of illness (days 1–3) since SARS patients can infect a large number of individuals during this period. The detection of viral RNA sequences using RT-PCR assays is currently the most widely used approach for early detection. However, the RT-PCR products need to be confirmed as SARS virus specific by other methods. We have developed an optical assay for SARS virus detection using oligonucleotide probes arrayed on thin-film biosensor chips. Because of the special optical characteristics of the chip surface, results can be visualized by the unaided human eye, making this technology “fieldable” and applicable in hospitals with only standard laboratory facilities. This system has been tested on SARS patient samples and the results will be discussed. So far, because of limitations in RT-PCR, the detection rate of SARS virus in patients at Day 1–3 is only about 20%. Here, we present two approaches we are exploring to increase this number significantly. The first focuses on modifications of current RT-PCR protocols in conjunction with optical assay to improve detection sensitivity. In the second, padlock probes (1) will be ligated directly to the viral RNA genome with subsequent isothermal exponential RCA (ERCA) (2), eliminating reverse transcription from RNA to DNA and PCR reactions. ERCA has been shown to achieve a target/signal amplification of >10 fold (2), several orders of magnitude greater than the routinely obtained by PCR. These studies could identify an optimal paradigm for the diagnosis of SARS as well as other RNA viral pathogens.